Opportunity timeline
In plain English
NINDS seeks a senior drug-development advisor with patient advocacy expertise to guide its Ultra-rare Gene-based Therapy Network. The work includes joining an external advisory board that may meet up to eight times a year, with occasional calls and a possible annual visit to the NIH campus. This is a small-business set-aside with a one-year base period and two option years, beginning November 6, 2026.
About this opportunity
COMBINED SYNOPSIS / SOLICITATION (COMPETITIVE) Title: Senior Advisor Subject Matter Expert (SME) with Patient Advocacy Expertise for the NINDS Ultra-rare Gene-based Therapy (URGenT) Network (i) This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with RFO Part 12. This announcement constitutes the only solicitation. Offers are being requested and a separate written solicitation will not be issued. The solicitation number is 7571PS27Q00015 issued as a Request for Quote for a Senior Advisor to act as a Subject Matter Expert (SME) with Patient Advocacy Expertise The Government reserves the right to make one award, multiple awards, or no…
Time remaining
Closes Nov 2, 2026
Related Opportunities

Robb Field Gateway Path

For On-Call Transportation Planning, Programs and Communications Support Services

Plant 134 Facility Assessment and Master Plan

Senior Advisor Subject Matter Expert (SME) with Pharmaceutical Development and Pain Expertise for the NINDS

Senior Advisor Subject Matter Expert (SME) with Pharmaceutical Development and Pain Expertise for the NINDS
Bid details are gathered and summarized automatically. Please verify details at the original source.
Ref No.
BS-5E3D9A

